Driving innovation and growth in the medical device industry.
Anasonic is a pioneering medical device company specializing in the development and manufacturing of ultrasound-based therapeutic devices. Established in December 2018, Anasonic is committed to improving the quality of life for patients suffering from chronic kidney disease (CKD) through innovative medical technologies. Our flagship technology, Low-Intensity Pliant Ultrasound (LIPUS), aims to enhance kidney function and reduce the need for dialysis.
Our History
Anasonic has achieved significant milestones since its inception, reflecting our dedication to innovation and excellence in medical device development.
2018
Anasonic established
________
2020
Partnership with Seoul St. Mary’s Hospital for glomerular filtration rate (GFR) regulation
________
2021
— Recognition of corporate research lab
— Certification as a venture business (innovation growth type)
________
2022
Certification as a small business
________
2023
— Patent registration for ultrasound-based device and method
________
2024
— GMP certification for medical devices
— Medical device approval (class 2 ultrasound stimulator)
— Expected exploratory clinical trials for kidney function improvement in CKD patients (Seoul St. Mary’s Hospital)
Our Partners
Anasonic is committed to fostering strategic partnerships to advance our technological capabilities and expand our market reach.
Catholic University of Korea
Potential Future Partnerships
Exploration of partnerships with leading healthcare providers and research institutions in Japan, the USA, and Europe to further validate and commercialize our technologies.
Wish to partner with us? Fill out our contact form by following the button link below.